We are live on ! Find out more
DCI

Data Collective IV Portfolio holdings

AUM $55.9M
1-Year Est. Return 49.14%
This Fund
S&P 500
This Quarter Est. Return
+75.39%
1 Year Est. Return
+49.14%
3 Year Est. Return
+250.98%
5 Year Est. Return
10 Year Est. Return
AUM
$130M
AUM Growth
+$43M
Cap. Flow
-$7.22M
Cap. Flow %
-5.56%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
RKLB icon
Rocket Lab Corp
RKLB
+$7.22M

Sector Composition

Rank Sector Weight
1 Industrials 76.32%
2 Healthcare 23.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVLV icon
1
Evolv Technologies
EVLV
$1.01B
$60.4M 46.5%
9,681,281
RKLB icon
2
Rocket Lab Corp
RKLB
$39.9B
$38.7M 29.82%
1,083,053
-294,890
-21% -$7.22M
RXRX icon
3
Recursion Pharmaceuticals
RXRX
$1.62B
$30.1M 23.14%
5,941,120
DFTX
4
Definium Therapeutics
DFTX
$5.57B
$651K 0.5%
100,350
ROIV icon
5
Roivant Sciences
ROIV
$24.3B
$43.7K 0.03%
3,875

Similar funds

Data Collective IV's Q2 2025 Portfolio in Review

As of Q2 2025, Data Collective IV held 5 positions worth $130M, up 49% from $86.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Data Collective IV withdrew a net $7.22M in Q2 2025, reducing 1 holding. Its largest reduction was Rocket Lab Corp, cutting an estimated $7.22M.

By sector, the portfolio is most concentrated in Industrials at 76% of assets, up from 63% a quarter earlier, followed by Healthcare.

  • Data Collective IV's biggest Q2 2025 reduction was Rocket Lab Corp, cutting an estimated $7.22M.
  • Data Collective IV's ten largest holdings make up 100% of its $130M portfolio in Q2 2025.
  • Data Collective IV opened 0 new positions and closed 0 in Q2 2025.
  • Data Collective IV's portfolio value rose 49% quarter-over-quarter to $130M.

Based on Data Collective IV's 13F filing for Q2 2025, filed 14 Aug 2025.